Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Circ Res ; 105(6): 604-9, 2009 Sep 11.
Article in English | MEDLINE | ID: mdl-19696410

ABSTRACT

RATIONALE: We studied a possibility that shRNAs can lead to transcriptional gene activation at the promoter level via epigenetic mechanism. OBJECTIVE: The purpose of this study was to test the effects on vascular endothelial growth factor (VEGF-A) expression by promoter targeted small hairpin RNAs (shRNAs) in vitro and in experimental animals in vivo using stable local lentiviral gene transfer. METHODS AND RESULTS: One shRNA was identified which strongly increased VEGF-A expression in C166 endothelial cells at mRNA and protein level whereas another shRNA decreased VEGF-A expression. Quantitative chromatin immunoprecipitation analysis revealed that the repressing shRNA caused epigenetic changes, which increased nucleosome density within the promoter and transcription start site and led to repression of VEGF-A expression. Epigenetic changes caused by the activating shRNA were opposite to those caused by the repressing shRNA. These results were confirmed in vivo in an ischemic mouse hindlimb model after local gene transfer where VEGF-A upregulation achieved by promoter-targeted shRNA increased vascularity and blood flow. CONCLUSIONS: We show that lentivirus-mediated delivery of shRNA molecules targeted to specific regions in the mVEGF-A promoter either induce or repress VEGF-A expression via epigenetic modulation. Thus, we describe a new approach of gene therapy, epigenetherapy, based on an epigenetic mechanism at the promoter level. Controlling transcription through manipulation of specific epigenetic marks provides a novel approach for the treatment of several diseases.


Subject(s)
Epigenesis, Genetic , Genetic Therapy/methods , Hindlimb/blood supply , Ischemia/therapy , Lentivirus , Promoter Regions, Genetic , RNA/biosynthesis , Vascular Endothelial Growth Factor A/genetics , Animals , Cell Line , Endothelial Cells/metabolism , Ischemia/genetics , Mice , RNA/genetics , Transcription, Genetic , Vascular Endothelial Growth Factor A/metabolism
2.
J Clin Endocrinol Metab ; 86(7): 3233-6, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11443194

ABSTRACT

Spondyloepiphyseal dysplasia tarda (SEDT) is an X-linked recessive disorder characterized by short stature due to defective growth of the vertebral bodies. In addition, deformities of the femoral heads result in early onset secondary osteoarthritis of the hips. The disorder affects males only with heterozygous female carriers showing no consistent abnormalities. The gene causing SEDT, which is located on Xp22.12-p22.31, consists of 6 exons of which only exons 3, 4, 5, and 6 are translated to yield an 140 amino acid protein, referred to as SEDLIN. SEDLIN mutations have been observed in SEDT patients, and we have undertaken studies to characterize such mutations in four unrelated SEDT kindreds by DNA sequence analysis. We identified two nonsense and two intragenic deletional frameshift mutations. The nonsense mutations occurred in exons 4 (TGG-->TGA, Trp70Stop) and 6 (CGA-->TGA, Arg122Stop). Both of the intragenic deletions, which were approximately 750 bp and 1300-1445 bp in size, involved intron 5 and part of exon 6 and resulted in frameshifts that lead to premature termination (Stop) signals. Thus, all four mutations are predicted to result in truncated proteins. The results of our study expand the spectrum of SEDLIN mutations associated with SEDT, and this will help to elucidate further the role of this novel protein in the etiology of this form of osteochondrodysplasia.


Subject(s)
DNA Mutational Analysis , Osteochondrodysplasias/genetics , X Chromosome , Codon, Nonsense , Exons , Female , Frameshift Mutation , Gene Deletion , Genetic Linkage , Humans , Male , Mutation , Pedigree , Proteins/genetics
3.
J Immunol Methods ; 166(1): 111-6, 1993 Nov 05.
Article in English | MEDLINE | ID: mdl-8228281

ABSTRACT

We report the development of a relatively quick and simple method for the assessment of X inactivation status for carrier determination in families affected by X-linked agammaglobulinemia (XLA). This method utilises an immunomagnetic separation technique for B cell purification and a polymerase chain reaction (PCR) based assay for the determination of methylation status at the androgen receptor (AR) gene locus to assess whether X inactivation is random or non-random at this locus. We report the results we have obtained using this assay to investigate females known to be carriers of various X-linked immunodeficiency disorders. In addition, we investigated four females from different families affected by XLA, two of whom were of unknown carrier status, and we discuss the results obtained with this and other X-inactivation assays. A similar assay has recently been described by Allen et al. (1992) and applied to members of one family affected by XLA.


Subject(s)
Agammaglobulinemia/genetics , Dosage Compensation, Genetic , Genetic Carrier Screening/methods , Agammaglobulinemia/diagnosis , B-Lymphocytes/metabolism , Base Sequence , Cell Separation , DNA/chemistry , DNA/genetics , DNA Primers/genetics , Female , Genetic Linkage , Humans , Methylation , Molecular Sequence Data , Polymerase Chain Reaction , Receptors, Androgen/genetics , X Chromosome
4.
Am J Med Genet ; 44(6): 834-8, 1992 Dec 01.
Article in English | MEDLINE | ID: mdl-1481858

ABSTRACT

We report the occurrence of Hunter disease (mucopolysaccharidosis type II) in a karyotypically normal girl who was one of identical twins. Molecular studies showed nonrandom X-inactivation in both her fibroblasts and lymphocytes, while her normal twin showed equal usage of both X chromosomes. In view of previous reports of 7 pairs of identical female twins in which one had Duchenne muscular dystrophy, it seems that twinning may be strongly associated with nonrandom X-inactivation, and is not specific to the properties of the disease causing gene.


Subject(s)
Diseases in Twins/genetics , Dosage Compensation, Genetic , Mucopolysaccharidosis II , Mucopolysaccharidosis II/genetics , Twins, Monozygotic , DNA Probes , Female , Fibroblasts/ultrastructure , Glycosaminoglycans/metabolism , Heterozygote , Humans , Iduronate Sulfatase/genetics , Infant, Newborn , Leukocytes/ultrastructure , Models, Genetic , Mucopolysaccharidosis II/embryology , Pedigree
5.
Indian J Exp Biol ; 37(2): 200-2, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10641147

ABSTRACT

The in vivo effects of insulin, and other insulino mimetic agents like vanadate and fenugreek (T. foenum graecum) were followed on the changes in the activities of creatine kinase in heart, skeletal muscle and liver of experimental diabetic rats. As compared to control rats, creatine kinase activities were found to decrease significantly in the tissues during experimental diabetes. All the antidiabetic compounds used namely, insulin, vanadate and Fenugreek seed powder normalised the decreased activities to almost control values. The effects of insulin and vanadate were comparable in restoring normoglycemia and the creatine kinase activities.


Subject(s)
Creatine Kinase/metabolism , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/enzymology , Hypoglycemic Agents/pharmacology , Animals , Female , Insulin/pharmacology , Liver/enzymology , Muscle, Skeletal/enzymology , Myocardium/enzymology , Plant Extracts/pharmacology , Plants, Medicinal , Rats , Rats, Wistar , Trigonella , Vanadates/pharmacology
6.
Ir Med J ; 84(4): 116-8, 1991.
Article in English | MEDLINE | ID: mdl-1817116

ABSTRACT

Being an X-linked condition, the sisters of men with X-linked agammaglobulinaemia have a 50% risk of being carriers of the disease gene (provided the disease has not developed as a results of a new mutation). We demonstrate how this risk can be modified very significantly by DNA analysis using linked DNA probes. The value of such tests for genetic purposes is discussed.


Subject(s)
Agammaglobulinemia/genetics , DNA Probes , Genetic Carrier Screening/methods , Genetic Linkage , X Chromosome , Adult , Female , Humans , Ireland , Male , Pedigree
7.
C R Acad Sci III ; 319(4): 263-8, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8762975

ABSTRACT

It is widely accepted that divalent cations can affect membrane excitability by interacting with negative charges on the membrane surface. This effect is generally supposed to arise from a modulation of the surface charge electrostatic field within the membrane. As an alternative mechanism, we propose that this effect may also be due to a generalized coupling between ion currents mediated by ionic composition changes at the membrane surface. To test this hypothesis we have computed the transmembrane potential using ionic current relations in which bulk external Ca2+ and K+ activities are substituted with superficial activities deduced from a Grahame-Langmuir isotherm. The model behavior agrees well with published results on Paramecium electrophysiology and furthermore explains 2 paradoxical observations on the cell membrane excitability upon changes of external Ca2+ and K+.


Subject(s)
Calcium Channels/analysis , Neurons/chemistry , Potassium Channels/analysis , Animals , Calcium Channels/physiology , Electrophysiology , In Vitro Techniques , Membrane Potentials , Models, Biological , Neurons/physiology , Paramecium/physiology , Potassium Channels/physiology
8.
Biophys J ; 81(5): 2442-57, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11606261

ABSTRACT

An electro-osmotic model is developed to examine the influence of plasma membrane superficial charges on the regulation of cell ionic composition. Assuming membrane osmotic equilibrium, the ion distribution predicted by Gouy-Chapman-Grahame (GCG) theory is introduced into ion transport equations, which include a kinetic model of the Na/K-ATPase based on the stimulation of this ion pump by internal Na(+) ions. The algebro-differential equation system describing dynamics of the cell model has a unique resting state, stable with respect to finite-sized perturbations of various types. Negative charges on the membrane are found to greatly enhance relaxation toward steady state following these perturbations. We show that this heightened stability stems from electrostatic interactions at the inner membrane side that shift resting state coordinates along the sigmoidal activation curve of the sodium pump, thereby increasing the pump sensitivity to internal Na(+) fluctuations. The accuracy of electrostatic potential description with GCG theory is proved using an alternate formalism, based on irreversible thermodynamics, which shows that pressure contribution to ion potential energy is negligible in electrostatic double layers formed at the surfaces of biological membranes. We discuss implications of the results regarding a reliable operation of ionic process coupled to the transmembrane electrochemical gradient of Na(+) ions.


Subject(s)
Cell Membrane/chemistry , Cell Membrane/metabolism , Ions/chemistry , Models, Biological , Sodium-Potassium-Exchanging ATPase/metabolism , Cells/metabolism , Ions/metabolism , Membrane Potentials/physiology , Osmosis/physiology , Sodium/metabolism , Static Electricity , Thermodynamics
9.
Acta Biotheor ; 48(3-4): 273-87, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11291945

ABSTRACT

The role of fixed charges present at the surface of biological membranes is usually described by the Gouy-Chapman-Grahame theory of the electric double-layer where the Grahame equation is applied independently on each side of the membrane and where the capacitive charges (linked to the transmembrane ionic currents) are disregarded. In this article, we generalize the Gouy-Chapman-Grahame theory by taking into account both intrinsic charges (resulting from the dissociation of membrane constituents) and capacitive charges, in the density value of the membrane surface charges. In the first part, we show that capacitive charges couple electrostatic potentials present on both sides of the membrane. The intensity of this coupling depends both on the value of the membrane specific capacitance and the transmembrane electric potential difference. In the second part, we suggest some physiological implications of membrane electric double-layers.


Subject(s)
Ion Channels/physiology , Membrane Potentials/physiology , Models, Theoretical
10.
Pflugers Arch ; 434(5): 559-67, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9242719

ABSTRACT

The contribution of the Na/K ATPase (pump) current to the polarization of the Purkinje cell has been studied using slices of the rat cerebellum by blocking the pump with dihydro-ouabain (DHO) while recording the membrane potential with microelectrodes in the somata. From our recordings, it appeared that blocking the pump depolarized the Purkinje cells more rapidly than might be expected from shifts in Na+ and K+ concentrations, suggesting the removal of a hyperpolarizing current. Application of DHO, in the presence of tetrodotoxin (TTX), led to calcium spike firing and plateau-like discharges suggesting activation of voltage-dependent calcium channels in the dendrites. Adding 2 mM CO2+ to the medium did not prevent the depolarizations. Removing calcium from the bathing medium containing 2 mM CO2+ blocked the spiking activity but DHO application still produced a depolarization. Experiments to measure the current inhibited by DHO indicated that the Na/K pump supplies a constant current of 240 pA. Substitution of the sodium with choline produced a hyperpolarization, during which DHO had no effect on the membrane potential. Substitution of the sodium with lithium produced only a slowly developing depolarization. It is concluded that in the cerebellar Purkinje cell, a continuous sodium ion influx activates the pumps which produce a current that directly contributes to the membrane polarization. Possible pathways for this sodium influx are discussed.


Subject(s)
Purkinje Cells/metabolism , Sodium-Potassium-Exchanging ATPase/physiology , Animals , Cell Membrane/physiology , Culture Media/pharmacology , Dose-Response Relationship, Drug , Electric Conductivity , In Vitro Techniques , Ouabain/analogs & derivatives , Ouabain/pharmacology , Purkinje Cells/drug effects , Rats , Rats, Sprague-Dawley , Sodium/pharmacology
12.
Mol Cell Biochem ; 210(1-2): 23-8, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10976754

ABSTRACT

The main purpose of this study was to investigate the effect of free radicals and experimental diabetes on cytosolic creatine kinase activity in rat heart, muscle and brain. Hydrogen peroxide decreased creatine kinase activity in a dose dependent manner which was reversed by catalase. Xanthine/xanthine oxidase, which produces superoxide anion, lowered the creatine kinase activity in the same manner whose effect was protected by superoxide dismutase. N-acetylcysteine and dithiothreitol also significantly ameliorated the effect of Xanthine/xanthine oxidase and hydrogen peroxide. Experimental diabetes of twenty-one days (induced by alloxan), also caused a similar decrease in the activity of creatine kinase. This led us to the conclusion that the decrease in creatine kinase activity during diabetes could be due to the production of reactive oxygen species. The free radical effect could be on the sulfhydryl groups of the enzyme at the active sites, since addition of sulfhydryl groups like N-acetylcysteine and dithiothreitol showed a significant reversal effect.


Subject(s)
Antioxidants/pharmacology , Creatine Kinase/metabolism , Free Radicals/metabolism , Hydrogen Peroxide/pharmacology , Sulfhydryl Compounds/pharmacology , Xanthine Oxidase/metabolism , Acetylcysteine/pharmacology , Animals , Blood Glucose/analysis , Brain/drug effects , Brain/enzymology , Catalase/pharmacology , Creatine Kinase/antagonists & inhibitors , Cytosol/enzymology , Diabetes Mellitus, Experimental/enzymology , Dithiothreitol/pharmacology , Dose-Response Relationship, Drug , Female , Free Radical Scavengers/pharmacology , Heart/drug effects , Insulin/administration & dosage , Insulin/blood , Muscle, Skeletal/drug effects , Muscle, Skeletal/enzymology , Myocardium/enzymology , Rats , Rats, Wistar , Superoxide Dismutase/pharmacology , Xanthine/pharmacology
13.
J Inherit Metab Dis ; 23(7): 669-76, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11117428

ABSTRACT

The high new mutation rate and the wide spectrum of mutations found in patients with ornithine carbamoyltransferase (OCT) deficiency means that direct mutation analysis is essential for providing accurate carrier detection and prenatal diagnosis in affected families. We present our strategy for mutation detection in the OCT gene and summarize the results from 31 families with a confirmed diagnosis and 34 families with a suspected diagnosis of OCT deficiency, and describe 14 previously unreported mutations.


Subject(s)
Mutation , Ornithine Carbamoyltransferase Deficiency Disease/enzymology , Ornithine Carbamoyltransferase/genetics , Alternative Splicing , Codon, Nonsense , Gene Deletion , Humans , Mutation, Missense , Ornithine Carbamoyltransferase Deficiency Disease/diagnosis , Ornithine Carbamoyltransferase Deficiency Disease/genetics , Point Mutation
14.
J Med Genet ; 30(6): 497-500, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8326493

ABSTRACT

We report a female infant born to a mother with incontinentia pigmenti (IP) and a father with haemophilia A, who manifests both disorders. Analysis of peripheral blood DNA from the infant, her mother, and two female relatives with IP showed a highly skewed pattern of X inactivation. Random patterns were observed in the infant's two sisters, who do not have IP and have normal carrier activity of factor VIII. Preferential inactivation of the X chromosome bearing the IP mutation, probably by negative selection, appears to have unmasked the factor VIII mutation on the infant's other X chromosome. This illustrates an unusual mechanism for the manifestation of an X linked disease in a heterozygous female.


Subject(s)
Dosage Compensation, Genetic , Hemophilia A/genetics , Incontinentia Pigmenti/genetics , Factor VIII/genetics , Family Health , Female , Genetic Carrier Screening , Hemophilia A/complications , Heterozygote , Humans , Incontinentia Pigmenti/complications , Infant , Pedigree
15.
J Med Genet ; 28(2): 117-21, 1991 Feb.
Article in English | MEDLINE | ID: mdl-2002481

ABSTRACT

We describe three families to highlight the variability of expression and penetrance that can occur in the craniosynostoses. In two of the families, gene carriers were only identified in retrospect by looking at photographs of other family members. In the third family, identical twins were initially thought to be discordant for sagittal craniosynostosis until early skull x rays were examined and both were found to be affected. The dilemmas faced when counselling these families are discussed.


Subject(s)
Craniosynostoses/genetics , Diseases in Twins , Genetic Counseling , Adult , Female , Hearing Loss, Sensorineural/genetics , Humans , Infant, Newborn , Male , Phenotype
16.
Muscle Nerve ; 16(1): 57-62, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8423832

ABSTRACT

A 30-year-old man with no family history of muscle disease presented with a progressive proximal myopathy and calf hypertrophy characteristic of Becker muscular dystrophy. A deletion of exons 45 to 48 in the dystrophin gene was confirmed by Southern blotting and multiplex polymerase chain reaction. However, muscle biopsy showed massive accumulation of glycogen, although no significant abnormality of glycolytic pathway enzymes could be demonstrated. This patient therefore has a previously undescribed myopathy associated with both Becker muscular dystrophy and a glycogen storage disorder of unknown aetiology.


Subject(s)
Dystrophin/genetics , Glycogen Storage Disease/complications , Muscular Dystrophies/complications , Adult , Gene Deletion , Glycogen Storage Disease/pathology , Glycogen Storage Disease/physiopathology , Humans , Male , Microscopy, Electron , Muscles/pathology , Muscles/ultrastructure , Muscular Dystrophies/genetics , Muscular Dystrophies/pathology , Muscular Dystrophies/physiopathology
17.
Hum Genet ; 99(5): 677-80, 1997 May.
Article in English | MEDLINE | ID: mdl-9150740

ABSTRACT

Severe combined immunodeficiency (SCID) is caused by a variety of underlying defects. Approximately 40% of cases are thought to be of the X-linked type (SCIDX1), which is phenotypically characterised by the absence, or very low numbers, of T cells, but normal or even high B cell numbers. The gene responsible for SCIDX1 is that coding for the common gamma chain (gamma c), a component of multiple cytokine receptors. Mutations in this gene have been demonstrated in a large number of boys affected by typical SCIDX1. We describe a sporadic case of a boy who had SCID with absent B cells and absent T cells, but in whom a mutation in the gamma c gene has been demonstrated. In the absence of a typical X-linked pedigree, the phenotype in this boy suggested an autosomal recessive form of SCID and the family would usually have been counselled accordingly. This family raises the question of the true frequency of SCIDX1 amongst sporadic male cases of SCID and highlights the need to screen these boys for gamma chain mutations.


Subject(s)
B-Lymphocytes/immunology , Point Mutation , Receptors, Cytokine/genetics , Receptors, Interleukin-2/genetics , Severe Combined Immunodeficiency/genetics , X Chromosome , Antigens, CD/immunology , DNA/blood , Exons , Humans , Infant , Male , Phenotype , Polymorphism, Single-Stranded Conformational , Severe Combined Immunodeficiency/immunology , T-Lymphocytes/immunology
18.
Hum Genet ; 96(4): 427-32, 1995 Oct.
Article in English | MEDLINE | ID: mdl-7557965

ABSTRACT

Mutations in the common gamma chain (gamma c or IL2RG) of the interleukin-2, -4, -7, -9 and -15 receptors have been found to cause X-linked severe combined immunodeficiency (SCIDX1). We report here on the mutations identified in a further ten families. Two of the mutations identified have occurred twice in unrelated families, indicating two possible mutational hotspots. Seven of the mutations, which were identified by single-strand conformational polymorphism (SSCP) analysis, are point mutations, and the eighth is a small deletion. We also report on the first use of assays based on these mutations within IL2RG for unambiguous carrier determination. The consequences for the gamma c proteins produced as a result of these mutations are discussed.


Subject(s)
Genetic Linkage , Genetic Testing , Mutation , Receptors, Interleukin-2/genetics , Severe Combined Immunodeficiency/genetics , X Chromosome , Base Sequence , Heterozygote , Humans , Male , Molecular Sequence Data , Pedigree , Polymorphism, Single-Stranded Conformational
19.
J Inherit Metab Dis ; 27(2): 179-86, 2004.
Article in English | MEDLINE | ID: mdl-15159648

ABSTRACT

The allopurinol test aims to distinguish carriers and noncarriers for ornithine transcarbamylase (OTC) deficiency. We have evaluated the reliability of the test in at-risk females of known genotype. Results based on urine orotidine and/or orotic acid measurement were compared in terms of sensitivity and specificity. Retrospectively, we analysed the results of allopurinol tests in 42 women (22 confirmed heterozygotes and 20 noncarriers) from 23 pedigrees at risk of being carriers for OTC deficiency. Using a cut-off of 2 standard deviations above the mean of controls, the highest sensitivity (91%) was given by orotidine alone or in combination with orotic acid, but specificity was only 70% and 65%, respectively. We conclude that the value of the allopurinol test for detecting OTC carriers in at-risk females is limited. This needs to be recognized when counselling families. The test still has a role as a safe, quick, noninvasive screen of individuals at risk, but test results in possible carriers should be interpreted with caution. In the absence of other supportive evidence, confirmation by mutation analysis is required.


Subject(s)
Allopurinol/urine , Genetic Carrier Screening/methods , Mass Screening/standards , Ornithine Carbamoyltransferase Deficiency Disease/diagnosis , Ornithine Carbamoyltransferase/genetics , Adult , Female , Genotype , Humans , Infant, Newborn , Male , Mass Screening/methods , Ornithine Carbamoyltransferase Deficiency Disease/epidemiology , Ornithine Carbamoyltransferase Deficiency Disease/genetics , Ornithine Carbamoyltransferase Deficiency Disease/urine , Pedigree , Reproducibility of Results , Retrospective Studies , Risk Factors
20.
J Med Genet ; 28(12): 860-4, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1757963

ABSTRACT

The genetic defects responsible for the allelic disorders of BMD and the more severe DMD have been shown to be mutations within the dystrophin gene, which encodes a 14 kb transcript. We describe here a BMD patient who belongs to a small class of subjects with large in frame deletions of the dystrophin gene that remove apparently dispensable coding sequence, thereby producing functional truncated dystrophin. The in vitro reconstruction of these deletion derivatives of full length dystrophin transcripts should enable higher efficiency transfection of human muscle or murine germline cells using retroviral based vectors, compared with the full length transcript. This capability offers a means of examining retroviral mediated transfer as a potential therapeutic strategy in severely affected DMD patients.


Subject(s)
Dystrophin/genetics , Muscular Dystrophies/genetics , Adult , Amino Acid Sequence , Base Sequence , Blotting, Southern , Chromosome Deletion , DNA , Genetic Therapy , Humans , Male , Molecular Sequence Data , Pedigree
SELECTION OF CITATIONS
SEARCH DETAIL